Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Strand Life Sciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10800
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequencing, high throughput microscopy and digital PCR. It offers clinical research and development services to pharmaceutical and biotechnology companies in the areas of clinical trial management, biomarker discovery, and validation. Strand Life’s software platform provides analysis, management and visualization tools for next-generation sequencing data. The company offers advisory services on genetics of cancer and inherited diseases. It operates in Bangalore, Ahmedabad, New Delhi, Gulbarga, Jaipur, Hosur, Hubli, Mumbai, Nagpur, Noida, Ghaziabad, Vizag and Cuttack. Strand Life is headquartered in Bangalore, Karnataka, India.

Strand Life Sciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Strand Life Sciences Raises US$10 Million In Series B Financing 11
Private Equity 12
Strand Life Sciences Raises up to USD12.4 Million in Private Equity Financing 12
Partnerships 13
ReadSense Genomic Center Enters into Co-Development Agreement with Strand Life Sciences 13
Tataa Biocenter Enters into Distribution Agreement with Strand Life Sciences 14
Strand Life Sciences to Form Joint Venture with MRIGlobal 15
Triesta Sciences To Form Joint Venture With Strand Life Sciences 16
Equity Offering 17
Strand Life Sciences Plans to Raise Funds Through IPO of Shares 17
Strand Life Sciences Pvt Ltd – Key Competitors 18
Strand Life Sciences Pvt Ltd – Key Employees 19
Strand Life Sciences Pvt Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Mar 13, 2018: High Prevalence of Hereditary Breast and/or Ovarian Cancer Among Patients in India 21
Jul 14, 2017: Cancer-causing BRCA Gene Mutations at Least Three Times More Prevalent in India Compared to Western Countries Reveals Study 22
Product News 23
Oct 17, 2017: Strand Life Sciences Announces the Release of Strand NGS v3.1 at ASHG 2017 23
Other Significant Developments 24
Sep 27, 2017: Strand Life Sciences to showcase Strand NGS, analysis software for next-generation sequencing data at ASHG 2017 24
Apr 03, 2017: Strand Life Sciences Creates Another Global Bioinformatics Landmark With Strand Ramanujan 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strand Life Sciences Raises US$10 Million In Series B Financing 11
Strand Life Sciences Raises up to USD12.4 Million in Private Equity Financing 12
ReadSense Genomic Center Enters into Co-Development Agreement with Strand Life Sciences 13
Tataa Biocenter Enters into Distribution Agreement with Strand Life Sciences 14
Strand Life Sciences to Form Joint Venture with MRIGlobal 15
Triesta Sciences To Form Joint Venture With Strand Life Sciences 16
Strand Life Sciences Plans to Raise Funds Through IPO of Shares 17
Strand Life Sciences Pvt Ltd, Key Competitors 18
Strand Life Sciences Pvt Ltd, Key Employees 19

List of Figures
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strand Life Sciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strand Life Sciences Pvt Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務情報
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Astellas Pharma Inc (4503):医療機器:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …
  • Dr. Paul Lohmann GmbH & Co KGaA:企業の戦略・SWOT・財務分析
    Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AVI Ltd:企業の戦略・SWOT・財務分析
    AVI Ltd - Strategy, SWOT and Corporate Finance Report Summary AVI Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Bajaj Finserv Limited:企業の戦略・SWOT・財務情報
    Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • POP Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary POP Biotechnologies Inc (POP Biotechnologies) is a biotechnology company that develops and harnesses nano-scale technologies. The company’s product portfolio comprises of NP-01, an encapsulated nanoparticle used to impart systemic drug release; and C36 product, a cobalt indulged nanoparticle …
  • Protalix BioTherapeutics Inc (PLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients wi …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The New York Times Company:企業の戦略・SWOT・財務分析
    The New York Times Company - Strategy, SWOT and Corporate Finance Report Summary The New York Times Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • LRAD Corporation:企業の戦略・SWOT・財務情報
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) operates as a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding …
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Abcam Plc (ABC):医療機器:M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • Cantel Medical Corp (CMD):企業の財務・戦略的SWOT分析
    Cantel Medical Corp (CMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Awilco LNG ASA (ALNG):企業の財務・戦略的SWOT分析
    Summary Awilco LNG ASA (Awilco LNG), a subsidiary of Awilhelmsen AS, is an oil and gas company that provides LNG transportation programs. The company owns and operates LNG vessels intended for international trading. It offers LNG value chain such as liquefaction, production, regasification, transpor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆